HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nonprofit Pharmaceutical Companies

419.757

-17.440-3.99%

Number of Gainers:5

Number of Losers:27

Number of Flat:2

PE:- -

High:441.043

Open:436.588

Low:416.263

Close:437.197

Loading ...

High Growth Tech Stocks in Asia to Watch for Promising Growth

Simply Wall St.

Everest Medicines Shares Surge 18% as First Patient Dosed in Cancer Drug Trial

MT Newswires Live

MicroPort CardioFlow to Narrow Losses in 2024; Shares Rise 7%

MT Newswires Live

Akeso Announces the Publication of Its Phase Iii Clinical Trial Results for Ivonescimab in Head-to-Head Comparison With Pembrolizumab in the Lancet

THOMSON REUTERS

Why Investors Shouldn't Be Surprised By Peijia Medical Limited's (HKG:9996) 31% Share Price Surge

Simply Wall St.

BRIEF-Microport Cardioflow Medtech Sees FY Net Loss RMB30 Million To RMB60 Million

Microport Cardioflow Medtech - Expected Result Due to Fair Value Gains on Convertible Instruments Issued by 4C Medical in FY, Others

THOMSON REUTERS

Microport Cardioflow Medtech Sees FY Net Loss RMB30 Mln to RMB60 Mln

THOMSON REUTERS

Hong Kong Stocks Surge on Arisen Expectations for Forceful Stimulus; Peijia Medical, HBM Surge Over 12%

MT Newswires Live

Everest Medicines Announces First Patient Dosed With Evm16, Its First Internally Developed Personalized Mrna Cancer Vaccine

THOMSON REUTERS

Everest Medicines Ltd - Evm16 Shows Synergistic Effect With Pd-1 Antibody in Preclinical Data

THOMSON REUTERS

Everest Medicines Ltd - Evm16 Well Tolerated and Safe in Preclinical Toxicity Studies

THOMSON REUTERS

CStone Pharmaceuticals Submit Clinical Trial Application in Australia for Cancer Drug

MT Newswires Live

HBM Holdings Receives Upfront Payment, Stake for Immunological Diseases Antibody

MT Newswires Live

China Designates Ascentage's Olverembatinib Cancer Therapy as Breakthrough Therapy

MT Newswires Live

Peijia Medical Completes First Two Implants with Transcatheter System; Shares Up 8%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":419.75656,"timestamp":1741594084391,"preClose":437.19687,"halted":0,"volume":125062844,"delay":0,"changeRate":-0.039891,"change":-17.440308,"pbRate":3.43319,"amount":2228559126,"amplitude":0.056681,"prevYearClose":331.1933,"fiveDayClose":410.09,"twentyDayClose":340.813,"turnoverRate":0.004845,"marketCap":234571806688,"floatMarketCap":221135631584,"peRate":-17.305245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":441.04327,"amplitude":0.056681,"preClose":437.19687,"low":416.2626,"pbRate":"3.43319","latestPrice":419.75656,"volume":125062844,"delay":0,"open":436.5877,"prevYearClose":331.1933,"prevWeekClose":437.197,"prevMonthClose":411.011,"prevQuarterClose":331.193,"fiveDayClose":410.09,"twentyDayClose":340.813,"sixtyDayClose":341.701,"secType":"PLATE","market":"HK","turnoverRate":0.004845,"peRate":-17.305245,"marketCap":234571806688,"floatMarketCap":221135631584,"timestamp":1741594084391,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":5,"down":27,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518226446","title":"High Growth Tech Stocks in Asia to Watch for Promising Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226446","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226446?lang=en_us&edition=fundamental","pubTime":"2025-03-10 06:05","pubTimestamp":1741557929,"startTime":"0","endTime":"0","summary":"As global markets face challenges such as trade policy uncertainties and inflation concerns, Asian tech stocks have been drawing attention for their potential to navigate these turbulent waters. In this environment, identifying promising high-growth tech stocks involves looking at companies with strong innovation capabilities and adaptability to shifting economic conditions.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/high-growth-tech-stocks-in-asia-to-watch-for-promising-growt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","01952","BK1161","BK1574"],"gpt_icon":0},{"id":"2517179442","title":"Everest Medicines Shares Surge 18% as First Patient Dosed in Cancer Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2517179442","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517179442?lang=en_us&edition=fundamental","pubTime":"2025-03-07 15:50","pubTimestamp":1741333820,"startTime":"0","endTime":"0","summary":"Everest Medicines  said the first patient was dosed in a clinical trial of its mRNA cancer vaccine EVM16 at Peking University Cancer Hospital,The study aims to assess the safety, tolerability, immunogenicity, and preliminary efficacy of EVM16 as a monotherapy and in combination with a PD-1 antibody in advanced or recurrent solid tumors.The clinical trial of EVM16 is being conducted jointly at Peking University Cancer Hospital and Fudan University Shanghai Cancer Center, according to a Thursday news release.Shares of the biopharmaceutical company soared 18% in recent trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01952","BK1161","BK1574","BK1583","MDCO"],"gpt_icon":0},{"id":"2517122378","title":"MicroPort CardioFlow to Narrow Losses in 2024; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517122378","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517122378?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:58","pubTimestamp":1741327136,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow Medtech  expects a net loss of between 30 million yuan and 60 million yuan in 2024, representing a decline of 87% to 94% from a year prior, according to a Thursday filing.The medical device maker attributed the forecast to the advancement of commercialization of certain products, higher overseas revenue, cost management, reversal of an impairment loss on an equity investment, and fair value gains on convertible instruments.Shares of the company were up 7% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1100","BK1574","BK1583","02160"],"gpt_icon":0},{"id":"2517129678","title":"Akeso Announces the Publication of Its Phase Iii Clinical Trial Results for Ivonescimab in Head-to-Head Comparison With Pembrolizumab in the Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2517129678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517129678?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:04","pubTimestamp":1741323844,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA5CG3YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348783233.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1161","LU1720050803.USD","IE00BPRC5H50.USD","LU0417516571.SGD","BK1574","09926","LU2488822045.USD","LU0348784397.USD"],"gpt_icon":0},{"id":"2517120012","title":"Why Investors Shouldn't Be Surprised By Peijia Medical Limited's (HKG:9996) 31% Share Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2517120012","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517120012?lang=en_us&edition=fundamental","pubTime":"2025-03-07 07:00","pubTimestamp":1741302017,"startTime":"0","endTime":"0","summary":"Peijia Medical Limited ( HKG:9996 ) shares have had a really impressive month, gaining 31% after a shaky period...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-9996/peijia-medical-shares/news/why-investors-shouldnt-be-surprised-by-peijia-medical-limite-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK1574","BK1100","BK1583","BK4211","09996"],"gpt_icon":1},{"id":"2517169811","title":"BRIEF-Microport Cardioflow Medtech Sees FY Net Loss RMB30 Million To RMB60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169811?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:05","pubTimestamp":1741273502,"startTime":"0","endTime":"0","summary":"BRIEF-Microport Cardioflow Medtech Sees FY Net Loss RMB30 Million To RMB60 MillionMarch 6  - Microport Cardioflow Medtech Corp 2160.HK:SEES FY NET LOSS RMB30 MILLION TO RMB60 MILLIONEXPECTED RESULT DUE TO FAIR VALUE GAINS ON CONVERTIBLE INSTRUMENTS ISSUED BY 4C MEDICAL IN FY, OTHERSFurther company coverage: 2160.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02160","BK1574","BK1583"],"gpt_icon":0},{"id":"2517501871","title":"Microport Cardioflow Medtech - Expected Result Due to Fair Value Gains on Convertible Instruments Issued by 4C Medical in FY, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2517501871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517501871?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:53","pubTimestamp":1741269200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP022:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1100","02160"],"gpt_icon":0},{"id":"2517150180","title":"Microport Cardioflow Medtech Sees  FY Net Loss RMB30 Mln to RMB60 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150180?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:53","pubTimestamp":1741269200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02160","BK1100","BK1574","BK1583"],"gpt_icon":0},{"id":"2517135443","title":"Hong Kong Stocks Surge on Arisen Expectations for Forceful Stimulus; Peijia Medical, HBM Surge Over 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517135443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517135443?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:55","pubTimestamp":1741251351,"startTime":"0","endTime":"0","summary":"Hong Kong stocks hit an almost three-year high, erasing any losses driven by the trade war with the U.S. on the arisen expectations that Beijing will introduce more stimulus to achieve the growth targ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HHImain","BK1583","02833","BK1574","02142","BK1100","BK1161","09996","513600","MCHmain","HSI"],"gpt_icon":1},{"id":"2517813874","title":"Everest Medicines Announces First Patient Dosed With Evm16, Its First Internally Developed Personalized Mrna Cancer Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2517813874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517813874?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:30","pubTimestamp":1741249803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA99ZLJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","BK1583","01952"],"gpt_icon":0},{"id":"2517613870","title":"Everest Medicines Ltd - Evm16 Shows Synergistic Effect With Pd-1 Antibody in Preclinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2517613870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517613870?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:30","pubTimestamp":1741249803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA99ZLJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","01952","BK1574","BK1161"],"gpt_icon":0},{"id":"2517138709","title":"Everest Medicines Ltd - Evm16 Well Tolerated and Safe in Preclinical Toxicity Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2517138709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517138709?lang=en_us&edition=fundamental","pubTime":"2025-03-06 16:30","pubTimestamp":1741249803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA99ZLJF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","01952","BK1574","BK1161"],"gpt_icon":0},{"id":"2517185242","title":"CStone Pharmaceuticals Submit Clinical Trial Application in Australia for Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517185242","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517185242?lang=en_us&edition=fundamental","pubTime":"2025-03-06 14:46","pubTimestamp":1741243589,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals  submitted the Phase I-B trial application in Australia for its large B-cell lymphoma  drug, according to a Thursday filing with the Hong Kong bourse.CS5001 is an ROR1-targeting antibody-drug conjugate  that works with first-line standard-of-care  to diffuse large B-cell lymphoma , the filing added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK4231","ADC","BK1574","XAO.AU","XJO.AU","ADC.AU","XKO.AU","BK7095","02616","BK4080"],"gpt_icon":0},{"id":"2517185660","title":"HBM Holdings Receives Upfront Payment, Stake for Immunological Diseases Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2517185660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517185660?lang=en_us&edition=fundamental","pubTime":"2025-03-06 14:40","pubTimestamp":1741243252,"startTime":"0","endTime":"0","summary":"HBM Holdings  received an upfront payment for its licensing agreement with Windward Bio AG, along with an equity interest in the latter's parent company, a Thursday Hong Kong bourse filing said.The company and Sichuan Kelun-Biotech Biopharmaceutical  had agreed to grant an exclusive license for their jointly developed HBM9378/SKB378, an anti-TSLP fully human antibody for immunological diseases, to Windward Bio, which could commercialize the drug worldwide aside from greater China and some other Southeast and West Asian countries.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06990","BK1583","02142","LU0196878994.USD","BK1574"],"gpt_icon":0},{"id":"2517183402","title":"China Designates Ascentage's Olverembatinib Cancer Therapy as Breakthrough Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517183402","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517183402?lang=en_us&edition=fundamental","pubTime":"2025-03-06 14:29","pubTimestamp":1741242590,"startTime":"0","endTime":"0","summary":"The Center for Drug Evaluation of China's National Medical Products Administration granted Ascentage Pharma Group International's  olverembatinib its third breakthrough therapy designation, a Thursday bourse filing said.The designation is for the drug's combination with low-intensity chemotherapy for treating newly-diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, a type of blood cancer caused by a genetic mutation in certain chromosomes.The drug has been granted breakthrough therapy designation twice before, once in March 2021 for the treatment of patients with chronic-phase chronic myeloid leukemia and then in June 2023 for patients with succinate dehydrogenase-deficient gastrointestinal stromal tumors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","06855","BK1161"],"gpt_icon":0},{"id":"2517002889","title":"Peijia Medical Completes First Two Implants with Transcatheter System; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517002889","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517002889?lang=en_us&edition=fundamental","pubTime":"2025-03-06 13:50","pubTimestamp":1741240218,"startTime":"0","endTime":"0","summary":"Peijia Medical  has completed the first two implants with the TrilogyTM Transcatheter Heart Valve System to treat severe aortic regurgitation in Taiwan, China, a Wednesday filing with the Hong Kong bourse said.The system is indicated for use in patients with symptomatic severe aortic regurgitation or symptomatic severe aortic stenosis who are at high risk for surgical aortic valve replacement.Shares of the company were up over 8% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09996","BK1583","BK1574","BK1100"],"gpt_icon":0}],"pageSize":16,"totalPage":4,"pageCount":1,"totalSize":62}]}}